ImmunoID NeXT® is a comprehensive tumor tissue profiling platform that delivers multidimensional insights into key areas of cancer biology. Leveraging an augmented whole exome sequencing (WES) and whole transcriptome sequencing (WTS) approach, our specialized analytics enable a panoramic view of the tumor and immune-microenvironment.
